# Template 6.3: Impact Pyramid Worksheet (3 Levels)

> **ëª©ì **: Impact Pyramidì˜ 3ë‹¨ê³„(Immediate 1-2yr, Medium 3-5yr, Long-term 10yr+)ë¥¼ ì²´ê³„ì ìœ¼ë¡œ ì„¤ê³„í•©ë‹ˆë‹¤. ê° ë ˆë²¨ë§ˆë‹¤ êµ¬ì²´ì ì´ê³  ì¸¡ì • ê°€ëŠ¥í•œ deliverablesë¥¼ ì •ì˜í•˜ì—¬, ì—°êµ¬ê°€ ë‹¨ê¸°/ì¤‘ê¸°/ìž¥ê¸°ì ìœ¼ë¡œ ì–´ë–¤ ì˜í–¥ì„ ë¯¸ì¹ ì§€ ëª…í™•ížˆ ì œì‹œí•©ë‹ˆë‹¤.

---

## ðŸ“Œ ì‚¬ìš© ë§¥ë½

**ì‚¬ìš© ì‹œì **: Template 6.2 (3-Stage Structure)ì˜ Impact ì„¹ì…˜ì„ ë” ê¹Šì´ ìžˆê²Œ í™•ìž¥í•  ë•Œ

**Activity**: ê°œë³„ ìž‘ì—… (15min) ë˜ëŠ” Template 6.2ì™€ í†µí•© ì‚¬ìš©
- **ëª©í‘œ**: ë‹¨ìˆœížˆ "ì˜í–¥ë ¥ ìžˆì„ ê²ƒ"ì´ ì•„ë‹ˆë¼, **ì–¸ì œ, ëˆ„ê°€, ì–´ë–»ê²Œ** í˜œíƒì„ ë°›ì„ì§€ êµ¬ì²´í™”
- **Figma**: Pyramid êµ¬ì¡°ë¥¼ ì‹œê°ì ìœ¼ë¡œ ìŒ“ì•„ì˜¬ë¦¬ë©° ìž‘ì„±

**í•™ìŠµ ëª©í‘œ**:
1. **Temporal Specificity**: ë‹¨ê¸°/ì¤‘ê¸°/ìž¥ê¸° ì˜í–¥ì„ ëª…í™•ížˆ êµ¬ë¶„
2. **Concrete Deliverables**: ì¸¡ì • ê°€ëŠ¥í•œ outputsì™€ outcomes ì •ì˜
3. **Broader Impact**: í•™ìˆ ì  ê¸°ì—¬ë¥¼ ë„˜ì–´ì„  ì‚¬íšŒì  ê°€ì¹˜ í‘œí˜„
4. **Realism Check**: Ambitiousí•˜ì§€ë§Œ achievableí•œ ì˜í–¥ ì„¤ê³„

---

## Figma Canvas êµ¬ì¡°

**Canvas Size**: 3840 Ã— 2160px (FigJam)

### Left Panel (800px) - Reference Materials

**Section 1: Impact Pyramid 3 Levels** (Read-only, 800 Ã— 700px)

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ ðŸ”ï¸ Impact Pyramid (Bottom-Up Construction)     â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                                 â”‚
â”‚         â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”             â”‚
â”‚         â”‚  LEVEL 3: LONG-TERM     â”‚             â”‚
â”‚         â”‚  (10+ years)            â”‚             â”‚
â”‚         â”‚  ðŸŒ Transformative      â”‚             â”‚
â”‚         â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜             â”‚
â”‚              â†‘ builds on                        â”‚
â”‚    â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”        â”‚
â”‚    â”‚  LEVEL 2: MEDIUM-TERM             â”‚        â”‚
â”‚    â”‚  (3-5 years)                      â”‚        â”‚
â”‚    â”‚  ðŸ“ˆ Adoption & Scaling            â”‚        â”‚
â”‚    â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜        â”‚
â”‚                   â†‘ builds on                   â”‚
â”‚ â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â” â”‚
â”‚ â”‚  LEVEL 1: IMMEDIATE                         â”‚ â”‚
â”‚ â”‚  (1-2 years)                                â”‚ â”‚
â”‚ â”‚  ðŸ“¦ Concrete Deliverables                   â”‚ â”‚
â”‚ â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜ â”‚
â”‚                                                 â”‚
â”‚ LEVEL 1: IMMEDIATE (1-2 years)                  â”‚
â”‚ â€¢ Publications (how many, which journals)       â”‚
â”‚ â€¢ Data/code sharing (what, where)              â”‚
â”‚ â€¢ Tools/protocols (who can use)                â”‚
â”‚ â€¢ Student training (how many, what skills)     â”‚
â”‚ â†’ Must be 100% achievable                      â”‚
â”‚                                                 â”‚
â”‚ LEVEL 2: MEDIUM-TERM (3-5 years)                â”‚
â”‚ â€¢ Method adoption (which labs/clinics)         â”‚
â”‚ â€¢ Program development (who implements)         â”‚
â”‚ â€¢ Policy influence (what level)                â”‚
â”‚ â€¢ Follow-up funding (what scale)               â”‚
â”‚ â†’ Dependent on Level 1 success, ~70% likely    â”‚
â”‚                                                 â”‚
â”‚ LEVEL 3: LONG-TERM (10+ years)                  â”‚
â”‚ â€¢ Paradigm shift (what changes in field)       â”‚
â”‚ â€¢ Practice transformation (which sectors)      â”‚
â”‚ â€¢ Population outcomes (what improves)          â”‚
â”‚ â€¢ Cross-disciplinary integration (which fields)â”‚
â”‚ â†’ Visionary but grounded, ~30% likely          â”‚
â”‚                                                 â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

**Section 2: NSF Broader Impact Criteria** (Read-only, 800 Ã— 500px)

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ ðŸŒ NSF Broader Impact Criteria                  â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                                 â”‚
â”‚ Your research should address 2-3 of these:      â”‚
â”‚                                                 â”‚
â”‚ 1. TEACHING/TRAINING/LEARNING                   â”‚
â”‚    â€¢ Graduate/undergrad training               â”‚
â”‚    â€¢ Curriculum development                    â”‚
â”‚    â€¢ Public education/outreach                 â”‚
â”‚                                                 â”‚
â”‚ 2. UNDERREPRESENTED GROUPS                      â”‚
â”‚    â€¢ Broadening participation                  â”‚
â”‚    â€¢ Diversity in research team                â”‚
â”‚    â€¢ Equity-focused applications               â”‚
â”‚                                                 â”‚
â”‚ 3. INFRASTRUCTURE ENHANCEMENT                   â”‚
â”‚    â€¢ New tools/databases                       â”‚
â”‚    â€¢ Research networks                         â”‚
â”‚    â€¢ Shared resources                          â”‚
â”‚                                                 â”‚
â”‚ 4. SOCIETAL BENEFIT                             â”‚
â”‚    â€¢ Health outcomes                           â”‚
â”‚    â€¢ Economic prosperity                       â”‚
â”‚    â€¢ National security                         â”‚
â”‚    â€¢ Quality of life                           â”‚
â”‚                                                 â”‚
â”‚ 5. DISSEMINATION                                â”‚
â”‚    â€¢ Beyond academic journals                  â”‚
â”‚    â€¢ Public engagement                         â”‚
â”‚    â€¢ Media/policy translation                  â”‚
â”‚                                                 â”‚
â”‚ TIP: Be specific about WHO benefits and HOW    â”‚
â”‚                                                 â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

**Section 3: Reality Check Questions** (Read-only, 800 Ã— 500px)

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ âœ… Reality Check: Ambitious vs. Hype            â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                                 â”‚
â”‚ LEVEL 1 (Immediate):                            â”‚
â”‚ â–¡ Can I guarantee these deliverables?          â”‚
â”‚ â–¡ Have I been conservative with numbers?       â”‚
â”‚ â–¡ Is timeline realistic (not optimistic)?      â”‚
â”‚                                                 â”‚
â”‚ LEVEL 2 (Medium-term):                          â”‚
â”‚ â–¡ Is adoption pathway plausible?               â”‚
â”‚ â–¡ Have I identified specific adopters?         â”‚
â”‚ â–¡ Is this conditional on Level 1 success?      â”‚
â”‚                                                 â”‚
â”‚ LEVEL 3 (Long-term):                            â”‚
â”‚ â–¡ Is vision inspiring but not grandiose?       â”‚
â”‚ â–¡ Can I defend "could" vs "will" claims?       â”‚
â”‚ â–¡ Am I using modal verbs (could, may, might)?  â”‚
â”‚                                                 â”‚
â”‚ BROADER IMPACT:                                 â”‚
â”‚ â–¡ Is it genuine (not forced)?                  â”‚
â”‚ â–¡ Have I specified WHO benefits?               â”‚
â”‚ â–¡ Have I explained HOW they benefit?           â”‚
â”‚                                                 â”‚
â”‚ HYPE ALERTS:                                    â”‚
â”‚ âŒ "Revolutionary", "paradigm-shifting" (hype)  â”‚
â”‚ âœ… "Could transform", "has potential to" (OK)   â”‚
â”‚ âŒ "Will save millions of lives" (over-promise) â”‚
â”‚ âœ… "Could improve outcomes for X population"(OK)â”‚
â”‚                                                 â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

---

### Right Panel (3040px) - Student Work Zones

**Layout**: Each student gets 1 vertical column (507px Ã— 2160px)

For 6 students: 6 columns Ã— 507px = 3042px

---

## Zone Layout (Per Student)

**Student Zone Structure**: 507px Ã— 2160px vertical

### Part 1: LEVEL 1 - Immediate Impact (507px Ã— 720px)

**Timeframe**: 1-2 years (within project duration)

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ Student A - LEVEL 1 (1-2 years)         â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                        â”‚
â”‚ ðŸ“¦ IMMEDIATE DELIVERABLES              â”‚
â”‚                                        â”‚
â”‚ A. PUBLICATIONS                        â”‚
â”‚ â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â” â”‚
â”‚ â”‚ How many papers: [Number]          â”‚ â”‚
â”‚ â”‚ Target journals: [List 2-3]        â”‚ â”‚
â”‚ â”‚ Topics: [Brief description each]   â”‚ â”‚
â”‚ â”‚                                    â”‚ â”‚
â”‚ â”‚ Example: "3 papers: (1) Behavioral â”‚ â”‚
â”‚ â”‚ biomarkers in JAMA Psychiatry,     â”‚ â”‚
â”‚ â”‚ (2) ML model in Psych Medicine,    â”‚ â”‚
â”‚ â”‚ (3) Clinical pilot in JMIR"        â”‚ â”‚
â”‚ â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜ â”‚
â”‚                                        â”‚
â”‚ B. DATA/CODE SHARING                   â”‚
â”‚ â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â” â”‚
â”‚ â”‚ What data: [Description]           â”‚ â”‚
â”‚ â”‚ Where shared: [Platform - OSF, etc]â”‚ â”‚
â”‚ â”‚ What code: [Analysis scripts, etc] â”‚ â”‚
â”‚ â”‚ Reuse potential: [Who can use it?] â”‚ â”‚
â”‚ â”‚                                    â”‚ â”‚
â”‚ â”‚ Example: "De-identified time-seriesâ”‚ â”‚
â”‚ â”‚ behavioral data (n=200) + Python   â”‚ â”‚
â”‚ â”‚ ML models on OSF. Enables other    â”‚ â”‚
â”‚ â”‚ labs to replicate or apply to      â”‚ â”‚
â”‚ â”‚ different populations."            â”‚ â”‚
â”‚ â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜ â”‚
â”‚                                        â”‚
â”‚ C. TOOLS/PROTOCOLS DEVELOPED           â”‚
â”‚ â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â” â”‚
â”‚ â”‚ What tool/protocol: [Name]         â”‚ â”‚
â”‚ â”‚ For whom: [Target users]           â”‚ â”‚
â”‚ â”‚ How accessed: [GitHub, website]    â”‚ â”‚
â”‚ â”‚                                    â”‚ â”‚
â”‚ â”‚ Example: "Open-source smartphone   â”‚ â”‚
â”‚ â”‚ risk monitoring system for         â”‚ â”‚
â”‚ â”‚ clinicians. Released on GitHub     â”‚ â”‚
â”‚ â”‚ with documentation, enables any    â”‚ â”‚
â”‚ â”‚ mental health clinic to deploy."   â”‚ â”‚
â”‚ â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜ â”‚
â”‚                                        â”‚
â”‚ D. STUDENT TRAINING                    â”‚
â”‚ â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â” â”‚
â”‚ â”‚ How many students: [Number]        â”‚ â”‚
â”‚ â”‚ Skills trained: [List]             â”‚ â”‚
â”‚ â”‚ Career outcomes: [Expected paths]  â”‚ â”‚
â”‚ â”‚                                    â”‚ â”‚
â”‚ â”‚ Example: "2 graduate students      â”‚ â”‚
â”‚ â”‚ trained in digital phenotyping,    â”‚ â”‚
â”‚ â”‚ machine learning, and clinical     â”‚ â”‚
â”‚ â”‚ implementation research. Both will â”‚ â”‚
â”‚ â”‚ pursue academic/industry careers   â”‚ â”‚
â”‚ â”‚ in computational psychiatry."      â”‚ â”‚
â”‚ â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜ â”‚
â”‚                                        â”‚
â”‚ TOTAL DELIVERABLES: [Summary sentence] â”‚
â”‚                                        â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

---

### Part 2: LEVEL 2 - Medium-Term Impact (507px Ã— 720px)

**Timeframe**: 3-5 years (post-project, early adoption)

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ ðŸ“ˆ LEVEL 2 (3-5 years)                  â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                        â”‚
â”‚ A. METHOD/TOOL ADOPTION                â”‚
â”‚ â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â” â”‚
â”‚ â”‚ Who will adopt: [Specific groups]  â”‚ â”‚
â”‚ â”‚ How many: [Estimated number]       â”‚ â”‚
â”‚ â”‚ Why realistic: [Adoption pathway]  â”‚ â”‚
â”‚ â”‚                                    â”‚ â”‚
â”‚ â”‚ Example: "10-20 research labs      â”‚ â”‚
â”‚ â”‚ (digital health, suicide research) â”‚ â”‚
â”‚ â”‚ will adopt passive sensing methods.â”‚ â”‚
â”‚ â”‚ Realistic because: (1) open-source â”‚ â”‚
â”‚ â”‚ code lowers barriers, (2) methods  â”‚ â”‚
â”‚ â”‚ applicable to many conditions,     â”‚ â”‚
â”‚ â”‚ (3) growing interest in digital    â”‚ â”‚
â”‚ â”‚ phenotyping (20 NIMH-funded labs)" â”‚ â”‚
â”‚ â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜ â”‚
â”‚                                        â”‚
â”‚ B. PROGRAM DEVELOPMENT                 â”‚
â”‚ â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â” â”‚
â”‚ â”‚ What programs: [Type]              â”‚ â”‚
â”‚ â”‚ Where implemented: [Settings]      â”‚ â”‚
â”‚ â”‚ Who implements: [Organizations]    â”‚ â”‚
â”‚ â”‚                                    â”‚ â”‚
â”‚ â”‚ Example: "5-10 mental health       â”‚ â”‚
â”‚ â”‚ clinics will pilot risk monitoring â”‚ â”‚
â”‚ â”‚ system. Veterans Affairs (VA)      â”‚ â”‚
â”‚ â”‚ and university counseling centers  â”‚ â”‚
â”‚ â”‚ are likely early adopters due to   â”‚ â”‚
â”‚ â”‚ high-risk populations and existing â”‚ â”‚
â”‚ â”‚ digital infrastructure."           â”‚ â”‚
â”‚ â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜ â”‚
â”‚                                        â”‚
â”‚ C. POLICY/GUIDELINE INFLUENCE          â”‚
â”‚ â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â” â”‚
â”‚ â”‚ What level: [Institutional/State/  â”‚ â”‚
â”‚ â”‚             National]              â”‚ â”‚
â”‚ â”‚ What recommendation: [Content]     â”‚ â”‚
â”‚ â”‚ Pathway: [How findings reach policyâ”‚ â”‚
â”‚ â”‚                                    â”‚ â”‚
â”‚ â”‚ Example: "Findings will inform     â”‚ â”‚
â”‚ â”‚ National Suicide Prevention        â”‚ â”‚
â”‚ â”‚ Lifeline's technology integration  â”‚ â”‚
â”‚ â”‚ guidelines. I will collaborate withâ”‚ â”‚
â”‚ â”‚ NIMH's Suicide Research Consortium â”‚ â”‚
â”‚ â”‚ to develop best practices for      â”‚ â”‚
â”‚ â”‚ digital risk monitoring."          â”‚ â”‚
â”‚ â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜ â”‚
â”‚                                        â”‚
â”‚ D. FOLLOW-UP FUNDING                   â”‚
â”‚ â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â” â”‚
â”‚ â”‚ Expected grants: [Type, scale]     â”‚ â”‚
â”‚ â”‚ Next questions: [Research agenda]  â”‚ â”‚
â”‚ â”‚                                    â”‚ â”‚
â”‚ â”‚ Example: "This R21 pilot will      â”‚ â”‚
â”‚ â”‚ position me for R01 ($2.5M, 5yr)   â”‚ â”‚
â”‚ â”‚ to test system effectiveness in    â”‚ â”‚
â”‚ â”‚ randomized trial (n=1000, 10       â”‚ â”‚
â”‚ â”‚ sites). Next: personalization      â”‚ â”‚
â”‚ â”‚ algorithms, integration with EHR." â”‚ â”‚
â”‚ â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜ â”‚
â”‚                                        â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

---

### Part 3: LEVEL 3 - Long-Term Vision (507px Ã— 720px)

**Timeframe**: 10+ years (transformative impact)

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ ðŸŒ LEVEL 3 (10+ years)                  â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                        â”‚
â”‚ A. PARADIGM SHIFT (if applicable)      â”‚
â”‚ â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â” â”‚
â”‚ â”‚ What changes: [Field's thinking/   â”‚ â”‚
â”‚ â”‚               approach]            â”‚ â”‚
â”‚ â”‚ From â†’ To: [Conceptual shift]      â”‚ â”‚
â”‚ â”‚                                    â”‚ â”‚
â”‚ â”‚ Example: "Suicide prevention could â”‚ â”‚
â”‚ â”‚ shift from reactive crisis responseâ”‚ â”‚
â”‚ â”‚ â†’ proactive continuous monitoring. â”‚ â”‚
â”‚ â”‚ From: Episodic clinic-based risk   â”‚ â”‚
â”‚ â”‚ assessment (snapshot, miss dynamic â”‚ â”‚
â”‚ â”‚ fluctuations)                      â”‚ â”‚
â”‚ â”‚ To: Real-time personalized risk    â”‚ â”‚
â”‚ â”‚ tracking (continuous, adaptive     â”‚ â”‚
â”‚ â”‚ to individual patterns)"           â”‚ â”‚
â”‚ â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜ â”‚
â”‚                                        â”‚
â”‚ B. PRACTICE TRANSFORMATION             â”‚
â”‚ â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â” â”‚
â”‚ â”‚ Which practices: [Clinical/Educ/   â”‚ â”‚
â”‚ â”‚                   Industry]        â”‚ â”‚
â”‚ â”‚ How they change: [Before vs After] â”‚ â”‚
â”‚ â”‚ Scope: [Scale of adoption]         â”‚ â”‚
â”‚ â”‚                                    â”‚ â”‚
â”‚ â”‚ Example: "Standard mental health   â”‚ â”‚
â”‚ â”‚ care could integrate continuous    â”‚ â”‚
â”‚ â”‚ behavioral monitoring, similar to  â”‚ â”‚
â”‚ â”‚ how diabetes care uses CGM         â”‚ â”‚
â”‚ â”‚ (continuous glucose monitoring).   â”‚ â”‚
â”‚ â”‚ If adopted by 10% of US clinics,   â”‚ â”‚
â”‚ â”‚ ~500K high-risk patients benefit." â”‚ â”‚
â”‚ â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜ â”‚
â”‚                                        â”‚
â”‚ C. POPULATION-LEVEL OUTCOMES           â”‚
â”‚ â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â” â”‚
â”‚ â”‚ What improves: [Health/Education/  â”‚ â”‚
â”‚ â”‚                Societal metric]    â”‚ â”‚
â”‚ â”‚ For whom: [Population]             â”‚ â”‚
â”‚ â”‚ How measured: [Indicator]          â”‚ â”‚
â”‚ â”‚                                    â”‚ â”‚
â”‚ â”‚ Example: "If widely implemented,   â”‚ â”‚
â”‚ â”‚ could contribute to reducing US    â”‚ â”‚
â”‚ â”‚ suicide rate (currently 14 per     â”‚ â”‚
â”‚ â”‚ 100K). Even a 10% reduction =      â”‚ â”‚
â”‚ â”‚ 4,500 lives saved annually.        â”‚ â”‚
â”‚ â”‚ Population: High-risk psychiatric  â”‚ â”‚
â”‚ â”‚ outpatients (~2M in US)."          â”‚ â”‚
â”‚ â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜ â”‚
â”‚                                        â”‚
â”‚ D. CROSS-DISCIPLINARY INTEGRATION      â”‚
â”‚ â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â” â”‚
â”‚ â”‚ Which fields: [Disciplines]        â”‚ â”‚
â”‚ â”‚ How integrated: [Collaboration/    â”‚ â”‚
â”‚ â”‚                  Method transfer]  â”‚ â”‚
â”‚ â”‚                                    â”‚ â”‚
â”‚ â”‚ Example: "Digital phenotyping      â”‚ â”‚
â”‚ â”‚ methods could extend to other      â”‚ â”‚
â”‚ â”‚ conditions: psychosis (early       â”‚ â”‚
â”‚ â”‚ warning signs), PTSD (trauma       â”‚ â”‚
â”‚ â”‚ triggers), addiction (relapse      â”‚ â”‚
â”‚ â”‚ prediction). Could create new      â”‚ â”‚
â”‚ â”‚ interdisciplinary field of         â”‚ â”‚
â”‚ â”‚ 'computational clinical psychology'â”‚ â”‚
â”‚ â”‚ bridging CS, psychiatry, stats."   â”‚ â”‚
â”‚ â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜ â”‚
â”‚                                        â”‚
â”‚ BROADER IMPACT SUMMARY (2-3 sentences) â”‚
â”‚ â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â” â”‚
â”‚ â”‚ Who benefits beyond academia:      â”‚ â”‚
â”‚ â”‚ [Patients, clinicians, society]    â”‚ â”‚
â”‚ â”‚                                    â”‚ â”‚
â”‚ â”‚ How they benefit: [Specific ways]  â”‚ â”‚
â”‚ â”‚                                    â”‚ â”‚
â”‚ â”‚ NSF criteria addressed: [Which 2-3]â”‚ â”‚
â”‚ â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜ â”‚
â”‚                                        â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

---

## Workshop Workflow (15ë¶„ - Optional Deep Dive)

**Note**: This can be used as:
1. Part of Template 6.2 (integrated into 30min workshop)
2. Standalone activity for deeper Impact elaboration
3. Homework assignment for refining proposal

### If Used as Standalone Activity (15ë¶„):

**Minute 0-10** (Individual Work):

**Task**:
- Expand Impact section from Template 6.2 using this pyramid structure
- Fill in all 3 levels with specific deliverables
- Use AI Prompts #11-14 to accelerate

**AI Prompts to Use**:
- **#11**: Immediate Impact â†’ generates Level 1 deliverables
- **#12**: Medium-term Impact â†’ generates Level 2 adoption pathways
- **#13**: Long-term Vision â†’ generates Level 3 transformative impact
- **#14**: Broader Impact â†’ adds NSF-specific societal benefit

**Instructor Guidance** (circulating):
- "Level 1 should be 100% achievable - be conservative"
- "Level 2 needs specific adopters - not just 'other researchers'"
- "Level 3 should use modal verbs: 'could transform' not 'will transform'"
- "Broader Impact: WHO benefits and HOW - be specific!"

**Common Issues to Watch**:
1. **Level 1 too ambitious**: "10 papers in 2 years"
   â†’ Fix: "3-4 papers is realistic for 2-year project"
2. **Level 2 too vague**: "Will have impact on the field"
   â†’ Fix: "10-20 labs in digital health will adopt methods"
3. **Level 3 pure hype**: "Will revolutionize mental health care"
   â†’ Fix: "Could shift clinical practice toward proactive monitoring"

---

**Minute 10-15** (Pair Discussion):

**Partner Exchange**:
- Pair with neighbor
- Each person shares their pyramid (2 min)
- Partner gives feedback using Reality Check questions (left panel)

**Feedback Questions**:
1. **Level 1**: Are these deliverables guaranteed? Any over-promises?
2. **Level 2**: Is the adoption pathway realistic? Who specifically will adopt?
3. **Level 3**: Is the vision inspiring but grounded? Any hype language?
4. **Broader Impact**: Who benefits beyond academia? How is it specific?

**Peer Feedback Format**:
- âœ… **Strongest level**: "Your Level [1/2/3] is most compelling because..."
- âš ï¸ **Needs realism check**: "Your Level [1/2/3] might be over-promising..."
- ðŸ’¡ **Suggestion**: "Consider quantifying [X] or specifying [Y]..."

---

## Example Fill-In (í•™ìƒ A - Suicide Prevention Research)

### LEVEL 1: Immediate Impact (1-2 years)

**A. Publications**:
```
3 papers:
(1) "Behavioral Signatures of Suicidal Crises: A Digital Phenotyping Study"
    â†’ Target: JAMA Psychiatry (IF 31.4)
(2) "Machine Learning for Dynamic Suicide Risk Prediction: Model Development and Validation"
    â†’ Target: Psychological Medicine (IF 10.6)
(3) "Implementing Smartphone-Based Risk Monitoring in Psychiatric Clinics: A Pilot Study"
    â†’ Target: JMIR Mental Health (IF 5.0)
```

**B. Data/Code Sharing**:
```
- De-identified time-series behavioral data from 200 participants (6 months each) shared on Open Science Framework (OSF)
- Python analysis scripts for feature extraction, ML model training (Random Forest, LSTM) on GitHub
- Enables replication and extension to other populations (veterans, adolescents) or conditions (psychosis, PTSD)
```

**C. Tools/Protocols**:
```
- Open-source "SuicideWatch" smartphone monitoring system (iOS/Android)
- Clinician dashboard for risk visualization
- Implementation guide for mental health clinics
- Released on GitHub with documentation, enables any clinic with EMR system to deploy
```

**D. Student Training**:
```
- 2 PhD students trained in:
  * Digital phenotyping methods (passive sensing, feature engineering)
  * Machine learning (supervised learning, time-series analysis)
  * Clinical implementation research (stepped-wedge designs)
  * Open science practices (data sharing, reproducible workflows)
- Career paths: Academic positions in computational psychiatry or industry (digital health startups)
```

**Summary**: "This research will produce 3 high-impact publications, open data/code enabling replication, a deployable risk monitoring system, and 2 PhD students trained in computational mental health methods."

---

### LEVEL 2: Medium-Term Impact (3-5 years)

**A. Method/Tool Adoption**:
```
10-20 research labs will adopt passive sensing methods:
- Digital mental health labs (e.g., Mohr Lab Northwestern, Onnela Lab Harvard)
- Suicide research groups (e.g., Franklin Lab FSU, Kleiman Lab Rutgers)
- Clinical psychology programs testing digital interventions

Realistic because:
(1) Open-source code lowers technical barriers
(2) Methods applicable to many conditions beyond suicide (depression, psychosis, PTSD)
(3) Growing NIMH funding for digital phenotyping (~20 R01s currently funded)
(4) Annual conference (Digital Biomarkers for Mental Health) creates dissemination venue
```

**B. Program Development**:
```
5-10 mental health clinics will pilot SuicideWatch system:
- Veterans Affairs (VA) mental health clinics: High-risk population, existing digital infrastructure
- University counseling centers: Young adult suicide epidemic, tech-savvy population
- Community mental health centers: Safety-net providers serving underserved populations

Implementation pathway:
Year 3-4: Collaborate with VA National Mental Health Technology Transfer Center
Year 4-5: Provide training workshops at Association for Behavioral and Cognitive Therapies (ABCT) annual meeting
```

**C. Policy/Guideline Influence**:
```
Institutional level:
- Findings will inform APA Clinical Practice Guidelines for Suicide Risk Assessment (revised every 10 years, next revision 2027)
- Collaborate with NIMH Suicide Research Consortium to develop best practices for digital risk monitoring

National level:
- Present findings to National Suicide Prevention Lifeline advisory board
- Inform standards for technology integration in crisis services
```

**D. Follow-up Funding**:
```
This R21 pilot ($275K, 2yr) positions me for:
- R01 full trial ($2.5M, 5yr): Multi-site randomized controlled trial (n=1000, 10 clinics) testing system effectiveness on reducing suicide attempts
- Next research questions:
  * Personalization algorithms (individual vs. population-level models)
  * Integration with electronic health records (interoperability)
  * Equity analysis (performance across demographic subgroups)
```

---

### LEVEL 3: Long-Term Vision (10+ years)

**A. Paradigm Shift**:
```
Suicide prevention could shift from reactive crisis response â†’ proactive continuous monitoring

From: Episodic clinic-based risk assessment
- Snapshots during scheduled appointments (weekly, monthly)
- Static self-report measures (missing dynamic fluctuations)
- Clinician relies on patient recall (subject to bias)
- Crisis often occurs between appointments (gaps in monitoring)

To: Real-time personalized risk tracking
- Continuous passive data collection (24/7 behavioral sensing)
- Dynamic models adapting to individual patterns (personalized baselines)
- Objective behavioral data complementing self-report
- Alerts enable timely intervention before crisis escalates

Analogous to transformation in diabetes care: fingerstick glucose tests â†’ continuous glucose monitoring (CGM)
```

**B. Practice Transformation**:
```
Standard mental health care could integrate continuous behavioral monitoring as routine practice:

Current practice:
- Risk assessment: Episodic (clinic visits only)
- Data source: Self-report + clinical interview
- Monitoring gap: Days-to-weeks between contacts

Future practice:
- Risk assessment: Continuous + episodic
- Data source: Self-report + passive behavioral sensors + clinical interview
- Monitoring gap: Real-time alerts for high-risk periods

Scope of adoption:
- If 10% of US mental health clinics adopt (1,500 of 15,000 clinics)
- Covering ~500,000 high-risk psychiatric outpatients annually
- Potential 10-20% reduction in suicide attempts (conservative estimate based on earlier intervention)
```

**C. Population-Level Outcomes**:
```
If widely implemented, could contribute to reducing US suicide rate:

Current: 14.0 per 100,000 (2020 CDC data) = ~46,000 deaths/year
Target: 10% reduction = 4,600 lives saved annually

Population impact:
- High-risk psychiatric outpatients: ~2 million in US
- If 25% covered by monitoring systems: 500,000 people
- Even modest effect (10% attempt reduction) = substantial public health impact

Measured by:
- National Violent Death Reporting System (NVDRS) suicide rates
- Hospital discharge data (suicide attempt admissions)
- Quality metrics for mental health clinics (crisis response time)
```

**D. Cross-Disciplinary Integration**:
```
Digital phenotyping methods could extend to other acute psychiatric conditions:
- Psychosis: Early warning signs of relapse (social withdrawal, sleep disruption)
- PTSD: Trauma trigger identification (location patterns, physiological arousal)
- Addiction: Relapse prediction (social context, craving patterns)
- Bipolar disorder: Mood episode onset (activity levels, circadian rhythms)

Could create new interdisciplinary field: "Computational Clinical Psychology"
- Bridging: Computer science (ML, mobile sensing) + Psychiatry (clinical phenomenology) + Statistics (time-series, causal inference)
- Training programs integrating CS and clinical psychology
- New journals, conferences, funding mechanisms
```

**Broader Impact Summary**:
```
This research will benefit patients (earlier intervention, reduced suffering), clinicians (objective risk data, improved decision-making), and society (lives saved, reduced healthcare costs from preventable crises). It addresses NSF Broader Impact criteria: (1) Advancing training through PhD student education in computational methods, (2) Enhancing research infrastructure through open-source tools and shared data, and (3) Benefiting society through improved mental health outcomes and suicide prevention.
```

---

## Instructor Facilitation Guide

### Before Workshop

**Prepare**:
1. Copy Figma template
2. Create student columns (6-12)
3. Ensure AI Prompts #11-14 are accessible
4. Prepare 1-2 example pyramids to share

**On Screen**:
- Display Impact Pyramid visual (left panel)
- Show Reality Check questions
- Have timer ready (10min work + 5min discussion)

---

### During Workshop

**Minute 0-10** (Individual Work):

**Opening**:
- "Impact Pyramid has 3 levels - think of it like building from concrete (Level 1) to visionary (Level 3)"
- "Level 1 must be 100% achievable, Level 3 can be aspirational"
- "Use AI prompts to generate, but review critically for realism"

**Circulating Feedback**:
- "Level 1 looks good - very concrete deliverables"
- "Level 2 needs specific adopters - which labs exactly?"
- "Level 3 has some hype language - change 'revolutionize' to 'could transform'"
- "Excellent Broader Impact - you specified WHO (patients, clinicians) and HOW (earlier intervention)"

**Common Interventions**:
1. **Over-promising**: "10 papers in 2 years is unrealistic - aim for 3-4"
2. **Vague adoption**: "Who are the 10-20 labs? Name a few examples"
3. **Hype**: "Use modal verbs: 'could', 'may', 'has potential to'"
4. **Missing WHO**: "Broader Impact says 'benefits society' - which part of society?"

---

**Minute 10-15** (Pair Discussion):

**Setup**:
- "Pair up with neighbor"
- "Each person: 2-min pitch of your pyramid"
- "Partner: Use Reality Check questions to give feedback"

**Monitor**:
- Listen for: "Is your Level 2 adoption pathway realistic?"
- Intervene if: Pairs are just complimenting, not critically evaluating
- Share: "Student C got great feedback - their partner identified hype language and suggested modal verbs"

**Wrap-up** (last 1 min):
- "Most common issue: Level 3 hype. Remember, 'could transform' not 'will revolutionize'"
- "Best practice: Quantify when possible - '10% reduction' is stronger than 'improve outcomes'"
- "Your Impact Pyramid is now ready to integrate into your full proposal"

---

### After Workshop

**Debrief**:
1. **Reality Check is critical**: Reviewers can spot over-promising instantly
2. **Specificity wins**: "10-20 labs" > "many researchers"
3. **Broader Impact is genuine**: Don't force it - find authentic societal connection
4. **Modal verbs are your friend**: "could", "may", "has potential to" show appropriate humility

**Common Mistakes**:
- Level 1: Over-ambitious (too many papers, unrealistic timeline)
- Level 2: No adoption pathway (just says "will be adopted")
- Level 3: Pure hype ("revolutionary", "transformative") without grounding
- Broader Impact: Generic ("advances science") instead of specific ("helps X population")

---

## Assessment Rubric (for instructor use)

**Level 1 Quality** (10 points):
- Specific deliverables (3 pts): Papers, data, tools, training all mentioned
- Realistic timeline (3 pts): Achievable in 1-2 years
- Quantified (2 pts): Numbers provided (how many papers, students, etc.)
- Reuse potential (2 pts): How others can build on outputs

**Level 2 Quality** (10 points):
- Adoption pathway (4 pts): Specific adopters identified, realistic mechanism
- Program development (3 pts): Concrete implementation plans
- Policy influence (2 pts): Plausible route to guidelines/recommendations
- Conditional on Level 1 (1 pt): Clearly builds on immediate outputs

**Level 3 Quality** (10 points):
- Vision inspiring (3 pts): Ambitious long-term goals
- Grounded in reality (3 pts): Not pure hype, uses modal verbs
- Population benefit (2 pts): Clear societal/health outcomes
- Cross-disciplinary (2 pts): Integration with other fields (if applicable)

**Broader Impact** (10 points):
- WHO specified (3 pts): Clear beneficiaries
- HOW specified (3 pts): Mechanism of benefit explained
- NSF criteria (2 pts): Addresses 2-3 NSF criteria
- Genuine (2 pts): Not forced, natural connection to research

**Total**: 40 points

**Excellent** (36-40): All levels complete, realistic, specific, compelling vision
**Good** (32-35): Most elements present, minor hype or vagueness
**Satisfactory** (28-31): Basic pyramid structure, needs more specificity
**Needs Improvement** (<28): Missing levels, unrealistic, or too vague

---

## Integration with Other Templates

**From Template 6.2**:
- Impact Articulation section (20%) expands into detailed 3-level pyramid here

**To Template 6.4**:
- Completed pyramids feed into Recipe Library Week 6
- Best Impact articulation prompts and examples collected

**For Final Proposal**:
- Level 1-3 content integrates into proposal's Impact/Broader Impact section
- Pyramid structure provides outline for writing
